The distinctive nature of HER2-positive gastric cancers

被引：13
|
作者：
Marano, L. [1 ]
Roviello, F. [1 ]
机构：
[1] Univ Siena, Dept Med Surg & Neurosci, Unit Gen & Minimally Invas Surg, I-53100 Siena, Italy
来源：
EJSO | 2015年 / 41卷 / 03期
关键词：
HER2; EXPRESSION; RECEPTOR; PROTEIN;
D O I：
10.1016/j.ejso.2014.12.007
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：271 / 273
页数：3
相关论文
共 50 条
  • [41] HER2 copy number as predictor of disease-free survival in HER2-positive resectable gastric adenocarcinoma
    Liu, Zimin
    Shi, Mingpeng
    Li, Xiaoxiao
    Song, Shanai
    Liu, Ning
    Du, Haiwei
    Ye, Junyi
    Li, Haiyan
    Zhang, Zhou
    Zhang, Lu
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (05) : 1315 - 1324
  • [42] p95HER2 expression in HER2-positive breast cancer with primary resistance
    Goh, Chih Wan
    Yang, Benlong
    Chi, Yayun
    Wu, Jiong
    PRECISION MEDICAL SCIENCES, 2024, 13 (02): : 99 - 106
  • [43] Long-term trastuzumab (Herceptin®) treatment in a continuation study of patients with HER2-positive breast cancer or HER2-positive gastric cancer
    Mueller, Volkmar
    Clemens, Michael
    Jassem, Jacek
    Al-Sakaff, Nedal
    Auclair, Petra
    Nuesch, Eveline
    Holloway, Debbie
    Shing, Mona
    Bang, Yung-Jue
    BMC CANCER, 2018, 18
  • [44] Trastuzumab emtansine (Kadcyla®) approval in HER2-positive metastatic breast cancers
    Guerin, Mathilde
    Sabatier, Renaud
    Goncalves, Anthony
    BULLETIN DU CANCER, 2015, 102 (04) : 390 - 397
  • [45] Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers
    Baldassarre, Tomas
    Truesdell, Peter
    Craig, Andrew W.
    BREAST CANCER RESEARCH, 2017, 19
  • [46] The landscape of d16HER2 splice variant expression across HER2-positive cancers
    Volpi, Chiara Costanza
    Pietrantonio, Filippo
    Gloghini, Annunziata
    Fuca, Giovanni
    Giordano, Silvia
    Corso, Simona
    Pruneri, Giancarlo
    Antista, Maria
    Cremolini, Chiara
    Fasano, Elena
    Saggio, Serena
    Faraci, Simona
    Di Bartolomeo, Maria
    de Braud, Filippo
    Di Nicola, Massimo
    Tagliabue, Elda
    Pupa, Serenella Maria
    Castagnoli, Lorenzo
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [47] Anchoring of hyaluronan glycocalyx to CD44 reduces sensitivity of HER2-positive gastric cancer cells to trastuzumab
    Chen, Si
    Zhang, Guoliang
    Liu, Yiwen
    Yang, Cuixia
    He, Yiqing
    Guo, Qian
    Du, Yan
    Gao, Feng
    FEBS JOURNAL, 2024, 291 (08) : 1719 - 1731
  • [48] Chk1 activation attenuates sensitivity of lapatinib in HER2-positive gastric cancer
    Bai, Ming
    Song, Na
    Che, Xiaofang
    Wang, Xiaoxun
    Qu, Xiujuan
    Liu, Yunpeng
    CELL BIOLOGY INTERNATIONAL, 2018, 42 (07) : 781 - 793
  • [49] The Evolution of Targeted Radionuclide Diagnosis of HER2-Positive Breast Cancer
    Bragina, Olga D.
    Deyev, Sergei M.
    Chernov, Vladimir, I
    Tolmachev, Vladimir M.
    ACTA NATURAE, 2022, 14 (02): : 4 - 15
  • [50] HER2 Directed Therapy for Gastric/Esophageal Cancers
    Won, Elizabeth
    Janjigian, Yelena J.
    Ilson, David H.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2014, 15 (03) : 395 - 404
12345